ReviewFrontiers in microbiology2025
Molecular epidemiology of methicillin-resistant
Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Molecular characterization of PVL-positive methicillin-resistant Staphylococcus aureus (MRSA) isolates from skin and soft tissue infections in Alexandria, Egypt.Archives of microbiology · 2026Article
- Molecular Characterization of Antimicrobial Resistance and Virulence Genotypes inPathogens (Basel, Switzerland) · 2026Article
- Differential Roles of Ag and ZnO in the Bactericidal Activity of Ag/ZnO-Hydroxyapatite Nanocomposites against Multidrug-Associated Methicillin-Resistant Staphylococcus aureus.Current microbiology · 2026Article
- Virulence Gene Profile and Antimicrobial Susceptibility ofMicroorganisms · 2026Article
- In Silico Prioritisation of Similarity-Selected Small Molecules Targeting the IsdB NEAT Domain ofInternational journal of molecular sciences · 2026Article
- Low Panton-Valentine leukocidin prevalence in circulating community MRSA: a genomic surveillance study in Qatar.BMC infectious diseases · 2026Article
- Methicillin-ResistantInternational journal of molecular sciences · 2026Review
- Prevalence, Antimicrobial Resistance, and Molecular Characteristics of MRSA in Saudi Arabia: A Retrospective Study.Microorganisms · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methicillin-resistant Aim: This scoping review evaluates MRSA data in GCC countries-United Arab Emirates (UAE), Saudi Arabia, Kuwait, Qatar, Oman, and Bahrain-focusing on prevalence trends, molecular characteristics, and gaps in the literature. Methods: A systematic search of the PubMed (National Library of Medicine [NLM], National Institutes of Health [NIH]) database was conducted to identify literature published between January 2010 and July 2025, using predefined keywords on MRSA epidemiology. Eligible studies were reviewed for MRSA prevalence, clonal diversity, antimicrobial resistance patterns, and virulence profiles. Results: Of 864 records screened, 97 met the inclusion criteria and were subjected to detailed review. Most studies originated from Saudi Arabia (58%), followed by Kuwait (26%), UAE (7%), Oman (3%), Qatar (2%), Bahrain (2%), and two involving adjacent countries (2%). Data indicate a predominance of community-associated MRSA (CA-MRSA) across both healthcare and community settings. Several studies reported novel or rare MRSA strains across various GCC countries. Moreover, there is clear evidence of widespread resistance to multiple classes of antibiotics, highlighting the growing concern of multidrug-resistant MRSA. Increasing prevalence of strains with virulence/resistance genes such as Conclusion: MRSA in the GCC shows dynamic and evolving patterns. Continuous surveillance through coordinated regional efforts is essential. A One Health approach, combined with strengthened antimicrobial stewardship, mandatory hospital screenings, and wastewater monitoring, could improve MRSA detection, tracking, and control across the region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.